B. Riley Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$659K Buy
5,219
+156
+3% +$20.6K 0.04% 403
2026
Q1
$690K Sell
5,063
-967
-16% -$135K 0.04% 370
2025
Q4
$740K Buy
6,030
+542
+10% +$65.9K 0.03% 406
2025
Q3
$609K Sell
5,488
-575
-9% -$65.4K 0.03% 472
2025
Q2
$672K Buy
+6,063
New +$645K 0.03% 437
2024
Q4
$1.1M Sell
11,919
-8,087
-40% -$728K 0.04% 427
2024
Q3
$1.68M Sell
20,006
-15,668
-44% -$1.2M 0.05% 361
2024
Q2
$2.45M Buy
35,674
+7,155
+25% +$477K 0.06% 297
2024
Q1
$2.14M Buy
28,519
+604
+2% +$46.4K 0.06% 334
2023
Q4
$2.26M Sell
27,915
-604
-2% -$47K 0.06% 333
2023
Q3
$2.14M Sell
28,519
-3,045
-10% -$234K 0.06% 334
2023
Q2
$2.43M Buy
31,564
+1,379
+5% +$110K 0.05% 316
2023
Q1
$2.5M Buy
30,185
+359
+1% +$29.7K 0.07% 292
2022
Q4
$2.56M Buy
29,826
+5,672
+23% +$449K 0.07% 282
2022
Q3
$1.49M Buy
24,154
+5,967
+33% +$376K 0.05% 381
2022
Q2
$1.13M Sell
18,187
-1,803
-9% -$112K 0.05% 384
2022
Q1
$1.19M Sell
19,990
-19,112
-49% -$1.22M 0.04% 432
2021
Q4
$2.84M Sell
39,102
-1,409
-3% -$97K 0.08% 265
2021
Q3
$2.83M Buy
40,511
+2,248
+6% +$158K 0.09% 256
2021
Q2
$2.63M Buy
38,263
+8,148
+27% +$544K 0.09% 272
2021
Q1
$1.95M Buy
30,115
+11,825
+65% +$762K 0.07% 310
2020
Q4
$1.07M Sell
18,290
-22,459
-55% -$1.36M 0.06% 307
2020
Q3
$2.6M Buy
40,749
+655
+2% +$45.4K 0.14% 164
2020
Q2
$3.08M Sell
40,094
-1,694
-4% -$130K 0.21% 120
2020
Q1
$3.13M Buy
41,788
+6,408
+18% +$443K 0.27% 88
2019
Q4
$2.3M Buy
35,380
+18,242
+106% +$1.19M 0.2% 115
2019
Q3
$1.09M Buy
17,138
+3,850
+29% +$252K 0.11% 210
2019
Q2
$898K Buy
13,288
+1,579
+13% +$104K 0.1% 220
2019
Q1
$763K Sell
11,709
-841
-7% -$55.9K 0.1% 233
2018
Q4
$786K Sell
12,550
-1,815
-13% -$127K 0.11% 195
2018
Q3
$1.11M Sell
14,365
-1,050
-7% -$79.3K 0.13% 171
2018
Q2
$1.09M Sell
15,415
-1,646
-10% -$116K 0.14% 169
2018
Q1
$1.29M Sell
17,061
-1,228
-7% -$97.6K 0.18% 134
2017
Q4
$1.31M Sell
18,289
-5,963
-25% -$453K 0.18% 144
2017
Q3
$1.97M Sell
24,252
-2,018
-8% -$154K 0.33% 84
2017
Q2
$1.86M Buy
26,270
+174
+0.7% +$11.6K 0.34% 82
2017
Q1
$1.77M Sell
26,096
-2,240
-8% -$158K 0.35% 71
2016
Q4
$2.03M Sell
28,336
-1,332
-4% -$99K 0.41% 56
2016
Q3
$2.02M Buy
29,668
+12,000
+68% +$975K 0.4% 55
2016
Q2
$1.48M Buy
17,668
+700
+4% +$62.1K 0.3% 81
2016
Q1
$1.56M Buy
16,968
+197
+1% +$17.8K 0.36% 67
2015
Q4
$1.7M Sell
16,771
-2,191
-12% -$228K 0.34% 75
2015
Q3
$1.86M Buy
18,962
+6,684
+54% +$742K 0.45% 45
2015
Q2
$1.44M Sell
12,278
-24
-0.2% -$2.62K 0.36% 63
2015
Q1
$1.21M Sell
12,302
-2,798
-19% -$284K 0.29% 90
2014
Q4
$7.87K Buy
15,100
+9,276
+159% +$959K 0.17% 140
2014
Q3
$662K Sell
5,824
-5,183
-47% -$508K 0.17% 159
2014
Q2
$429K Buy
11,007
+4,484
+69% +$349K 0.1% 223
2014
Q1
$462K Buy
6,523
+1,884
+41% +$148K 0.14% 166
2013
Q4
$348K Buy
4,639
+488
+12% +$34K 0.11% 206
2013
Q3
$261K Sell
4,151
-1,041
-20% -$62.2K 0.09% 256
2013
Q2
$266K Buy
+5,192
New +$271K 0.09% 254

Other funds holding GILD

B. Riley Wealth Advisors's GILD Position: Q2 2026 in Review

B. Riley Wealth Advisors increased its Gilead Sciences (GILD) stake by 3.1% in Q2 2026, buying an estimated $20.6K and bringing the position to 5,219 shares worth $659K. The position accounts for 0.04% of the portfolio, ranked #403.

B. Riley Wealth Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.13M in Q1 2020. 722 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • B. Riley Wealth Advisors held 5,219 shares of Gilead Sciences worth $659K as of Q2 2026.
  • B. Riley Wealth Advisors bought 156 Gilead Sciences shares in Q2 2026, an estimated $20.6K.
  • Gilead Sciences made up 0.04% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #403 holding.
  • B. Riley Wealth Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • B. Riley Wealth Advisors's Gilead Sciences position peaked at $3.13M in Q1 2020.
  • 722 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.